Bausch Health Companies (BHC) Inventory (2009 - 2026)
Bausch Health Companies (BHC) posted Inventory of $1.6 billion for Q2 2026, little changed sequentially from $1.6 billion in Q1 2026, and down 3.2% YoY from $1.7 billion in Q2 2025.
Bausch Health Companies (BHC) Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Inventory for 18 years, with the latest figure at $1.6 billion in Q2 2026.
- Quarterly Inventory fell 3.2% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 3.2% YoY) and the FY2025 annual result came in at $1.6 billion, up 2.13% from the prior year.
- Inventory steadied at $1.6 billion in Q2 2026 per BHC's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Inventory peaked at $1.7 billion in Q3 2024 and troughed at $1.0 billion in Q1 2022.
- A 5-year average of $1.4 billion and a median of $1.6 billion in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2025: Inventory jumped 41.65% in 2023, then retreated 3.44% in 2025.
- Over 5 years, Inventory stood at $1.1 billion in 2022, then surged by 41.65% to $1.5 billion in 2023, then increased by 3.3% to $1.6 billion in 2024, then grew by 2.13% to $1.6 billion in 2025, then retreated by 1.66% to $1.6 billion in 2026.
- According to Business Quant data, Inventory over the past three periods registered $1.6 billion, $1.6 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.55 Bn | 39.89 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.85 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.37 Bn | 19.71 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 816.00 Mn |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 1.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.60 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.60 Bn |
| Jun 30, 2025 | 1.66 Bn |
| Mar 31, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.60 Bn |
| Sep 30, 2024 | 1.66 Bn |
| Jun 30, 2024 | 1.61 Bn |
| Mar 31, 2024 | 1.64 Bn |
| Dec 31, 2023 | 1.54 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.09 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.07 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 993.00 Mn |
| Sep 30, 2021 | 1.06 Bn |